Mangafodipir Trisodium vs Trastuzumab

## Mangafodipir Trisodium vs Trastuzumab: Overview

This comparison examines the pharmacological differences between **Mangafodipir Trisodium** and **Trastuzumab**.

## Mechanism of Action

**Trastuzumab**: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

## Pharmacokinetics

**Half-life**: Mangafodipir Trisodium — N/A; Trastuzumab — 28 days.

## Chemical Properties

**Type**: Mangafodipir Trisodium — Small molecule; Trastuzumab — Antibody.